Serge Marchand is a professor at the Faculty of Medicine and Health Sciences of the University of Sherbrooke and Scientific Director of Lucine, a Bordeaux-based digital therapy company. Doctor in neurological sciences from the University of Montreal and a postdoctoral fellowship from the University of California at San Francisco (UCSF), he served as Scientific Director of CRCHUS from 2008 to 2013. He was Scientific Director of the Fonds de recherche en santé du Québec from 2017 to 2019 and Vice President of Scientific Affairs at Génome Québec from 2019 to 2020. He is the author of several articles, books and book chapters on pain. His research focuses on the neurophysiological mechanisms responsible for the development, persistence and response to treatments of chronic pain.

Career highlights :

• Discovery of the importance of endogenous pain modulation mechanisms in the development, persistence and treatment of pain

University studies

• Bachelor of Applied Science, Psychoeducation (Université du Québec en Abitibi-Témiscamingue, 1983)
• Master of Science, Kinesthesiology (Université du Québec à Trois-Rivières, 1986)
• Doctor of Philosophy, Neuroscience (Université de Montréal (1992)
• Post-Doctorat, Pain Neuroanatomy (University of California, San Francisco, 1994)

Teaching experiences

• Professor at University of Sherbrooke
• Regular participation in several conferences
• Continuing Medical Education